Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Indoco Remedies Limited ( (IN:INDOCO) ) has shared an announcement.
Indoco Remedies Limited announced that the Goods and Service Tax (GST) Authority has dropped proceedings against the company regarding a Show Cause Notice (SCN) related to issues like excess claim of Input Tax Credit (ITC) and GSTR9C reconciliation. The resolution of this matter indicates no financial or operational impact on the company, which is a positive development for its stakeholders and market positioning.
More about Indoco Remedies Limited
Indoco Remedies Limited operates in the pharmaceutical industry, providing a range of products including formulations and active pharmaceutical ingredients. The company focuses on both domestic and international markets, catering to various therapeutic segments.
YTD Price Performance: -29.78%
Average Trading Volume: 7,050
Current Market Cap: 21.5B INR
Learn more about INDOCO stock on TipRanks’ Stock Analysis page.